Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,669,891 Wol.
$7,669,891 Wol.
Dec 31, 2026
↑2k
99%
↑3k
62%
↑4k
28%
↑5k
14%
↑7,5 tys.
14%
↑10k
10%
↑12,5 tys.
5%
$7,669,891 Wol.
$7,669,891 Wol.
Dec 31, 2026
↑2k
$45,436 Wol.
99%
↑3k
$50,414 Wol.
62%
↑4k
$170,864 Wol.
28%
↑5k
$215,382 Wol.
14%
↑7,5 tys.
$174,338 Wol.
14%
↑10k
$6,493,848 Wol.
10%
↑12,5 tys.
$344,846 Wol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Dec 1, 2025, 12:56 PM ET
Wolumen
$7,669,891Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,669,891Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania